Serum interleukin-6 is associated with hypocalcemia, hypoferritinemia and hyperkalemia in end-stage renal disease patients. Italian Journal of Medicine, [S. l.], v. 16, n. 1, 2022. DOI: 10.4081/itjm.2022.1550. Disponível em: https://www.italjmed.org/ijm/article/view/1550. Acesso em: 4 jul. 2025.